ST Premium
For just $1, you can unlock ST Grading’s top-rated stocks that consistently beat the market. Our AI-powered Smart Screener finds winning trades in seconds, helping you uncover hidden opportunities before others do.
Ready to Win Big?
Try Now for Just $1!© 2025 Stocks Telegraph All rights reserved.
Most stock quote data provided by financialmodelingprep.com
Absci Corporation (ABSI) stock declined over -3.10%, trading at $2.81 on NASDAQ, down from the previous close of $2.90. The stock opened at $2.86, fluctuating between $2.80 and $2.93 in the recent session.
Absci Corporation, a drug and target discovery company, provides biologic drug candidates and production cell lines using integrated drug creation platform for partners in the United States. Its integrated drug creation platform enables the creation of biologics by unifying the drug discovery and cell line development processes into one process. Absci Corporation was founded in 2011 and is headquartered in Vancouver, Washington.
Employees | 155 |
Beta | 2.1 |
Sales or Revenue | $5.72M |
5Y Sales Change% | 1.782% |
Fiscal Year Ends | December |
Sector | Healthcare |
Industry | Biotechnology |